SERPINF2 and ovarian serous adenocarcinoma: Previous studies have indicated a correlation between SERPINF2 with unfavorable outcomes in advanced serous ovarian cancer, and laboratory tests have confirmed its crucial involvement in tumor growth and spread (Huh et al., 2022).